Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 3

2(25.0%)

8Total

N/A(6)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT02253108Not ApplicableActive Not Recruiting

The OCT SORT-OUT VIII Study

Role: collaborator

NCT05989074Not ApplicableUnknown

All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve

Role: collaborator

NCT03952273Not ApplicableActive Not Recruiting

Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent

Role: collaborator

NCT02165670Withdrawn

BASIC VALIDATE Coronary Stent Registry

Role: collaborator

NCT05331547Unknown

BioFreedom™ BA9™ Ultra

Role: collaborator

NCT01813435Phase 3Completed

GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

Role: collaborator

NCT01760083Not ApplicableCompleted

A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions

Role: collaborator

NCT01486095Not ApplicableUnknown

COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study

Role: collaborator

NCT01137019Phase 3Unknown

Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition

Role: collaborator

NCT01956448Not ApplicableCompleted

SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®

Role: collaborator

All 10 trials loaded